Gotowe bibliografie tematyczne / Oral Antidiabetic

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Oral Antidiabetic”

Autor: Grafiati
Data publikacji: 2 czerwca 2025
Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Oral Antidiabetic”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Oral Antidiabetic"

1

Nana, Nurhasanah Rumanda, Khairunnisa, and Urip Harahap. "Potential Drug Interactions Of Oral Antidiabetic In Prescriptions Of Type 2 Diabetes Mellitus Patients At Kumpulan Pane Hospital." International Journal of Science, Technology & Management 2, no. 4 (2021): 1378–82. http://dx.doi.org/10.46729/ijstm.v2i4.278.

Pełny tekst źródła
Streszczenie:

 
 
 
 Diabetes Mellitus is a disease that can cause complications of other diseases so that the treatment to be given becomes more and this has the potential for interactions between drugs that can affect the physiological condition of the patient. The aim of this study is to analyze the potential of oral antidiabetic interactions on prescription at Kumpulan Pane Hospital. Analysis of potential oral antidiabetic interactions on a prescription using quantitative research methods is retrospective descriptive. Prescriptions used are inpatient and outpatient prescriptions for
Style APA, Harvard, Vancouver, ISO itp.
2

Lukito, Johan Indra. "Antidiabetik Oral Kombinasi Penghambat DPP-4 dan Penghambat SGLT-2." Cermin Dunia Kedokteran 48, no. 12 (2021): 692–95. http://dx.doi.org/10.55175/cdk.v48i12.157.

Pełny tekst źródła
Streszczenie:
Dalam tatalaksana diabetes melitus tipe 2, terapi kombinasi dua obat antidiabetik disarankan jika dengan monoterapi gagal mencapai target kontrol glikemik. Pemilihan jenis obat antidiabetik tergantung kondisi pasien dan profil obat. Kombinasi obat antidiabetik oral golongan penghambat DPP-4 (dipeptidyl peptidase-4) dan penghambat SGLT-2 (sodium-glucose cotransporter type 2) dapat menjadi salah satu pilihan.
 Combination of two antidiabetic drugs is recommended in the management of type 2 diabetes mellitus if monotherapy fails to achieve glycemic control targets. Choice of antidiabetic dru
Style APA, Harvard, Vancouver, ISO itp.
3

Lukito, Johan Indra. "Antidiabetik Oral Kombinasi Penghambat DPP-4 dan Penghambat SGLT-2." Cermin Dunia Kedokteran 48, no. 12 (2021): 692. http://dx.doi.org/10.55175/cdk.v48i12.1572.

Pełny tekst źródła
Streszczenie:
<p>Dalam tatalaksana diabetes melitus tipe 2, terapi kombinasi dua obat antidiabetik disarankan jika dengan monoterapi gagal mencapai target kontrol glikemik. Pemilihan jenis obat antidiabetik tergantung kondisi pasien dan profil obat. Kombinasi obat antidiabetik oral golongan penghambat DPP-4 (dipeptidyl peptidase-4) dan penghambat SGLT-2 (sodium-glucose cotransporter type 2) dapat menjadi salah satu pilihan.</p><p>Combination of two antidiabetic drugs is recommended in the management of type 2 diabetes mellitus if monotherapy fails to achieve glycemic control targets. Choic
Style APA, Harvard, Vancouver, ISO itp.
4

Dascultu, Dana Adriana, Elena Madalina Petran, and Coriolan Emil Ulmeanu. "Epidemiology in oral antidiabetic poisoning in children and adolescents – a four-year study in a pediatric poison centre." Romanian Journal of Pediatrics 70, no. 1 (2021): 53–57. http://dx.doi.org/10.37897/rjp.2021.1.10.

Pełny tekst źródła
Streszczenie:
Oral antidiabetics have become a common etiology associated with acute poisoning in children. The study shall carry out an analysis of the demographic characteristics, circumstantial characteristics and clinical profile associated with oral antidiabetic poisoning. An observational, descriptive and retrospective study was carried out over a period of 4 years including children confirmed with the diagnosis of acute poisoning with oral antidiabetics. In the study group, there is a prevalence of voluntary acute poisoning in female patients in the 15 to 18 year age group. bIn the group study biguan
Style APA, Harvard, Vancouver, ISO itp.
5

Lebovitz, Harold E. "Oral Antidiabetic Agents." Drugs 44, Supplement 3 (1992): 21–28. http://dx.doi.org/10.2165/00003495-199200443-00004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Scheen, J., and Pierre J. Lef??bvre. "Oral Antidiabetic Agents." Drugs 55, no. 2 (1998): 225–36. http://dx.doi.org/10.2165/00003495-199855020-00004.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Krentz, Andrew J., and Clifford J. Bailey. "Oral Antidiabetic Agents." Drugs 65, no. 3 (2005): 385–411. http://dx.doi.org/10.2165/00003495-200565030-00005.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Melander, A., L. O. Almér, G. Sartor, B. Scherstén, and E. Wåhlin-Boll. "Oral Antidiabetic Therapy." Acta Medica Scandinavica 210, S656 (2009): 55–57. http://dx.doi.org/10.1111/j.0954-6820.1982.tb07704.x.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Hidayati, Nur Rahmi, Dyah Aryani Perwitasari, Imaniar Noor Faridah, and Rinto Susilo. "Effect of Gene Polymorphisms on Oral Antidiabetic Drug Response in Patients With Type 2 Diabetes Mellitus." Sciences of Pharmacy 4, no. 2 (2025): 72–80. https://doi.org/10.58920/sciphar0402321.

Pełny tekst źródła
Streszczenie:
Diabetes mellitus is currently one of the global health threats. The prevalence and incidence of this disease continue to increase, both in industrialised and developing countries, including Indonesia. There are different types of DM marker gene polymorphisms in each racial group. These genetic variations contribute to the response of oral antidiabetic drugs. This article aims to conduct a narrative review of the influence of gene polymorphisms on oral antidiabetic drug response in patients with type 2 diabetes mellitus. Article searches were conducted in PubMed, Scopus, Google Scholar, and Wi
Style APA, Harvard, Vancouver, ISO itp.
10

Bintang, Sri. "EVALUASI ORAL ANTIDIABETIK PADA PASIEN DIABETES MELITUS TIPE 2 DI RSUD "X" LAMONGAN." Journal of Herbal, Clinical and Pharmaceutical Science (HERCLIPS) 2, no. 1 (2021): 1. http://dx.doi.org/10.30587/herclips.v2i1.2188.

Pełny tekst źródła
Streszczenie:
Diabetes Mellitus Type 2 is a metabolic disorder characterized by an increase in blood sugar due to decreased insulin secretion by pancreatic beta cells and or insulin function disorders (insulin resistance). This study aims to evaluate oral antidiabetics in patients with type 2 diabetes mellitus at the Regional General Hospital dr. Soegiri Lamongan. This research design is descriptive with a population of all type 2 diabetes mellitus patients from July to August 2019 using a total sampling technique. The number of samples in this study were 64 patients. The results showed that the most prescr
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Oral Antidiabetic"

1

Stankūnaitė, Eglė. "Pharmacoepidemiological study and costs analysis of oral antidiabetic drugs and insulins in Lithuania on 2006-2009 year." Master's thesis, Lithuanian Academic Libraries Network (LABT), 2010. http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2010~D_20100621_092504-76708.

Pełny tekst źródła
Streszczenie:
Objective: To perform pharmacoepidemiological study of the use of oral antidiabetic drugs and insulins in Lithuania on 2006-2009 year and cost-minimization and reference price analysis enabling more rational use of financial resources of national health system. Material ans methods: The search for all literature relating to pharmacokinetic and pharmacodynamic chareacteristics of drugs for diabetes mellitus was done in MEDLINE database. The data on total sales of oral antidiabetic drugs and insulins in Lithuania over a four-year period (2006-2009) were obtained from Softdent, Lithuania data ba
Style APA, Harvard, Vancouver, ISO itp.
2

Davis-Ajami, Mary Lynn. "The association between joblessness and adult working age diabetic oral antidiabetic medication adherence and health services utilization." The Ohio State University, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=osu1282067521.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Steyn, Rianda. "The usage of antidiabetic drugs : a managed care approach / Rianda Steyn." Thesis, North-West University, 2005. http://hdl.handle.net/10394/1029.

Pełny tekst źródła
Streszczenie:
"Diabetes mellitus" refers to a spectrum of conditions, which all present with hyperglycaemia as a common medical finding. Diabetes was once thought of as a single disease, but according to Setter et a/. (2000:378), it includes a heterogeneous group of disorders that are secondary to various genetic predispositions and precipitating factors. Type 1 diabetes mellitus (DM) accounts for 10 to 15% of all cases of diabetes mellitus and is clinically characterised by hyperglycaemia and a propensity to diabetic keto-acidosis. Its control requires chronic insulin treatment. Although it may occur at an
Style APA, Harvard, Vancouver, ISO itp.
4

Shenolikar, Rahul. "Racial differences in oral antidiabetic medication adherence, healthcare utilization and costs associated with type 2 diabetes in medicaid enrollees." The Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc_num=osu1156948396.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Niemi, Mikko. "Effects of induction and inhibition of cytochrome P-450 enzymes on the pharmacokinetics and pharmacodynamics of oral antidiabetic drugs." Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/laa/kliin/vk/niemi/.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Heitzmann, Thomas. "Untersuchungen zur Pharmakokinetik der Alpha-aktivierten Carbonsäuren (-)-BM 13.1074, BM 17.0505, BM 13.1196, BM 13.1188 und BM 13.1180 sowie der Thiazolidindione CS-045, BM 13.1244,BM 13.1246, BM 13.1215 und BM 50.1050 als potentielle orale Antidiabetika /." [S.l. : s.n.], 1994. http://www.gbv.de/dms/bs/toc/156825465.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Lu, I.-Chia, and 魯怡佳. "Decomposition of factors influencing expenditure variation of oral antidiabetic drugs." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/8qnety.

Pełny tekst źródła
Streszczenie:
碩士<br>國立臺灣大學<br>健康政策與管理研究所<br>106<br>Objective: This study aimed to describe the trends in the use and spending on oral antidiabetic drugs and to explore factors that influenced expenditure variation in Taiwan during 2009-2013. Methods: Data were extracted from National Health Insurance Research Database (NHIRD). Using a non-stochastic, index-theoretical method, changes in expenditures on oral antidiabetic drugs were decomposed into 6 cost-impact determinants: prescription volume, prescription size, price, generic use, therapeutic mix, and drug mix. These 6 determinants could be classified int
Style APA, Harvard, Vancouver, ISO itp.
8

Silva, Susana Melissa Ribeiro da. "Abdominal Aortic Aneurysm: a review on the role of oral antidiabetic drugs." Master's thesis, 2020. https://hdl.handle.net/10216/128689.

Pełny tekst źródła
Streszczenie:
Introdução: Uma relação negativa paradoxal entre a Diabetes Mellitus e a prevalência e crescimento de um Aneurisma da Aorta Abdominal está estabelecida. Todavia, ainda não foi possível determinar se esta proteção é conferida pela Diabetes Mellitus ou pelo tratamento dirigido à Diabetes. O objetivo deste manuscrito é rever a associação entre antidiabéticos orais e a incidência e crescimento dos AAA. Métodos: Uma pesquisa foi conduzida nas bases de dados Pubmed e Scopus até dezembro de 2019 por forma a identificar publicações que reportem a associação entre antidiabéticos orais (biguanidas/metfo
Style APA, Harvard, Vancouver, ISO itp.
9

Silva, Susana Melissa Ribeiro da. "Abdominal Aortic Aneurysm: a review on the role of oral antidiabetic drugs." Dissertação, 2020. https://hdl.handle.net/10216/128689.

Pełny tekst źródła
Streszczenie:
Introdução: Uma relação negativa paradoxal entre a Diabetes Mellitus e a prevalência e crescimento de um Aneurisma da Aorta Abdominal está estabelecida. Todavia, ainda não foi possível determinar se esta proteção é conferida pela Diabetes Mellitus ou pelo tratamento dirigido à Diabetes. O objetivo deste manuscrito é rever a associação entre antidiabéticos orais e a incidência e crescimento dos AAA. Métodos: Uma pesquisa foi conduzida nas bases de dados Pubmed e Scopus até dezembro de 2019 por forma a identificar publicações que reportem a associação entre antidiabéticos orais (biguanidas/metfo
Style APA, Harvard, Vancouver, ISO itp.
10

Adeyemi, Ayoade Olayemi. "Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes." Thesis, 2011. http://hdl.handle.net/2152/ETD-UT-2011-05-2759.

Pełny tekst źródła
Streszczenie:
The present study involved the analyses of the Texas Medicaid prescription claims data. The population studied was made up of subjects between 10 and 18 years who had at least 2 prescriptions of the same oral antidiabetic (OAD) medication from January 1, 2006 through December 31, 2009. Twelve months’ data for each subject were analyzed. The main aim of the study was to describe OAD medication use patterns in the study population, assess trends in Medication Possession Ratio (MPR) and persistence in the study population and determine the relationship between age and MPR and between age and pers
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Oral Antidiabetic"

1

Kuhlmann, Jochen, and Walter Puls, eds. Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

J, Ahr H., Kuhlmann J, and Puls Walter, eds. Oral antidiabetics. Springer, 1996.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Møller, J. Toxic oral antidiabetics in relation to cardiovascular disease. ecomed, 1988.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

(Editor), Jochen Kuhlmann, and W. Puls (Editor), eds. Oral Antidiabetis. Springer, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Kuhlmann, Jochen, and Walter Puls. Oral Antidiabetics. Springer London, Limited, 2013.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Aumüller, W. Oral wirksame Antidiabetika. Brand: Springer, 2011.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Pengaruh diit, latihan fisik, dan pemberian obat antidiabetik oral terhadap triad lipid darah penderita baru diabetes mellitus tipe-II laki-laki: Laporan penelitian. Departemen Pendidikan dan Kebudayaan R.I., Direktorat Jenderal Pendidikan Tinggi, Universitas Sumatera Utara, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Części książek na temat "Oral Antidiabetic"

1

Bailey, Clifford J., and Andrew J. Krentz. "Oral Antidiabetic Agents." In Textbook of Diabetes. Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444324808.ch29.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Bischoff, H., and H. E. Lebovitz. "Oral Antidiabetic Drugs in Research and Development." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_23.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Bhandari, Prasan. "Insulin and oral antidiabetic agents." In Pharmacology Mind Maps for Medical Students and Allied Health Professionals. CRC Press, 2019. http://dx.doi.org/10.1201/9780429023859-53.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Lotz, N., W. Bachmann, H. Mehnert, and E. Standi. "Combining insulin with oral antidiabetic agents (including problems of secondary failure)." In Pharmacology of Diabetes, edited by C. E. Mogensen and E. Standl. De Gruyter, 1990. http://dx.doi.org/10.1515/9783110850321-010.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Altmann, J., A. W. Kornhuber, and H. H. Kornhuber. "Riskfactors of „Normal“ Alcohol Consumption, Oral Antidiabetic Drugs, and Treatment of Stroke." In Verhandlungen der Deutschen Gesellschaft für Neurologie. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-83201-7_203.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Kuhlmann, J. "Introduction." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Prugnard, E., and M. Noel. "Chemistry and Structure-Activity Relationships of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_10.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Prugnard, E., and M. Noel. "Physicochemical Properties and Analytical Methods of Determination of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Wiernsperger, N. F. "Preclinical Pharmacology of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_12.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Schmidt, F., F. Hartig, W. Rebel, and P. Ochlich. "Toxicology of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_13.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Oral Antidiabetic"

1

Selvaag, Edgar, Anita B. Petersen, Robert Gniadecki, Tine Thorn, and Hans Christian Wulf. "Antidiabetics and diuretics show phototoxicity in HaCaT cells." In European Conference on Biomedical Optics. Optica Publishing Group, 2001. http://dx.doi.org/10.1364/ecbo.2001.4433_158.

Pełny tekst źródła
Streszczenie:
The antidiabetics tolbutamide, glibenclamide, and glipizide, and the diuretics bendroflumethiazide, butizide, furosemide, hydrochlorothiazide, and trichlormethiazide were investigated for potential phototoxicity in the HaCaT cell line. The cells were incubated with the drugs and then exposed to UVA1 irradiation. The effects of the antioxidants L-ascorbic acid, and α-tocopherol on oxidative DNA damage were assessed. Bendroflumethiazide, furosemide, hydrochlorothiazide, trichlormethiazide, or tolbutamide induced dose-dependent phototoxicity. Cells incubated with bendroflumethiazide, tolbutamide,
Style APA, Harvard, Vancouver, ISO itp.
2

Dwita, Lusi Putri, Vivi Anggia та Tri Dewi Prasetyatuti. "Artocarpus altilis Leaves Activity in Inhibiting α-Amylase Enzyme as Oral Antidiabetic Drug Candidate". У Bromo Conference, Symposium on Natural Products and Biodiversity. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008359301680173.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Sophie Holdt-Caspersen, Nynne, Stine Hangaard Casper, Peter Vestergaard, Claus Dethlefsen, and Morten Hasselstrøm Jensen. "The Adherence to Oral Second Line Antidiabetic Medication in People with Type 2 Diabetes - A Protocol for a Systematic Review." In 18th Scandinavian Conference on Health Informatics. Linköping University Electronic Press, 2022. http://dx.doi.org/10.3384/ecp187035.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Ibrahim, Khadega, Chiara Cugno, and Md Mizanur Rahman. "Conjugated Linoleic Acid (CLA) co-treatment alleviates antidiabetic drug, rosiglitazone associated deterioration of bone remodeling." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0148.

Pełny tekst źródła
Streszczenie:
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia due to decreased insulin secretion, defective action or both. The rosiglitazone (RSG) is one of the oral antidiabetic drug used in type 2 (T2) DM and has a unique insulin-sensitizing capacity. However, RSG has a negative side effect on the bone as it stimulates the differentiation of bone marrow-mesenchymal stromal cells (BM-MSCs) into adipocytes at the expense of osteoblasts in the bone marrow microenvironment, disturbing the normal balance of bone remodeling and causing BM adiposity. On the other hand, the t
Style APA, Harvard, Vancouver, ISO itp.
5

Grigoli, Marina, Danielle de Oliveira, Paloma Zanarelli, Patrícia Manzine, and Márcia Cominetti. "INSULIN PATHWAY PROTEINS ARE ALTERED IN PATIENTS WITH CONCOMITANT ALZHEIMER’S DISEASE AND DIABETES MELLITUS." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda001.

Pełny tekst źródła
Streszczenie:
Background: Alterations in the insulin pathway proteins have been associated with brain disorders, including Alzheimer’s disease (AD). Objectives: To investigate the peripheral levels of the insulin pathway proteins between cognitively and metabolically preserved participants, patients with DM2, AD and those with the concomitant presence of AD and DM2. Methods: The study was approved by the UFSCar’s ethics committee (CAAE: 31634720.9.0000.5504). Patients were diagnosed with AD using the criteria of the National Institute on Aging/Alzheimer’s Association (NIA/AA). DM2 was defined as self-report
Style APA, Harvard, Vancouver, ISO itp.
6

Hallur, Raghavendra, Anushka Sahay, Sarwan Bradosty, and Faiyaz Shaikh. "Inhibitory Effects of a Specific Phytochemical Combination on Carbohydrate Metabolism, Lipid Digestion, and Free Radicals: An in Vitro Study." In 5th International Conference on Biomedical and Health Sciences. Cihan University-Erbil, 2024. http://dx.doi.org/10.24086/biohs2024/paper.1247.

Pełny tekst źródła
Streszczenie:
Abstract—Context: Diabetes, characterized by insulin insufficiency/resistance and oxidative stress, is a global health concern. Traditional plant combinations offer potential as oral diabetes therapy due to their multifaceted pharmacological properties. Aims: This study evaluated the antidiabetic, antilipidemic, and antioxidant potential of a phytochemical combination comprising Salacia extracts (Salacia chinensis and Salacia oblonga), Curcumin, and Piperine. Settings and Design: In vitro experiments assessed the inhibitory activity of the phytochemical combination on key enzymes related to ca
Style APA, Harvard, Vancouver, ISO itp.
7

Selvaag, Edgar, Helle Anholt, Johan Moan, and Per Thune. "Phototoxicity to sulphonamide-derived oral antidiabetics and diuretics: comparative in-vitro and in-vivo investigations." In BiOS Europe '97, edited by Kristian Berg, Benjamin Ehrenberg, Zvi Malik, Johan Moan, and Abraham Katzir. SPIE, 1997. http://dx.doi.org/10.1117/12.297815.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Fitriani, Rina, Muhammad Amir Masruhim, and Dewi Rahmawati. "ANALISA TINGKAT KEPATUHAN PENGGUNAAN TERAPI OBAT ORAL ANTIDIABETIK (OAD) PADA PASIEN DIABETES MELLITUS DI INSTALASI RSUD. A.W SJAHRANIE." In Mulawarman Pharmaceuticals Conferences. Fakultas Farmasi, Universitas Mulawarman, Samarinda, 2015. http://dx.doi.org/10.25026/mpc.v2i1.40.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Pfohl, M., S. Pscherer, A. Fritsche, H. Anderten, K. Pegelow, and J. Seufert. "Wirksamkeit von Insulin glargin 300 E/ml (Gla-300) bei Neueinstellung von Typ-2-Diabetespatienten auf eine basalunterstützte orale Therapie (BOT) nach Versagen der oralen Antidiabetika- (OAD-)Therapie – 6-Monats-Ergebnisse der Toujeo-1-Studie." In Diabetes Kongress 2018 – 53. Jahrestagung der DDG. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1641916.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Oral Antidiabetic"

1

Yibchok-anun, Sirinthorn, Wijit Banlunara, and Sirichai Adisakwattana. Antidiabetic effects, mechanisms of of p-methoxy-trans-cinnamic acid. Faculty of Veterinary Science, Chulalongkorn University, 2008. https://doi.org/10.58837/chula.res.2008.81.

Pełny tekst źródła
Streszczenie:
p-Methoxycinnamic acid (p-MCA) is a cinnamic acid derivative that shows various pharmacologic actions such as neuroprotective and hepatoprotective activities. To examine the insulinotropic activity of p-MCA, the perfused rat pancreas and a pancreatic β-cell line, INS-1 were used in the studies. P-MCA increased insulin secretion from the perfused rat pancreas and INS-1 cells in a concentration-dependent manner. In addition, p-MCA increased intracellular Ca²⁺ concentration ([Ca²⁺]i) in INS-1 cells. The p-MCA-induced insulin secretion and rise in [Ca²⁺]i were markedly inhibited in the absence of
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Oral Antidiabetic” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii